Dr. Pratyusha Bala

Technical Associate (Experimental)

Qualification

Ph.D. (Cancer Genomics)

Experience

• Working as Technical Associate (Experimental), NGC, CDFD since November,2019
• Worked in Centre for DNA Fingerprinting and Diagnostics w.e.f July,2013 to November,2019

Publications

• PAN-INDIA 1000 SARS-CoV-2 RNA Genome Sequencing Reveals Important Insights into the Outbreak (2020). bioRxiv preprint doi: https://doi.org/10.1101/2020.08.03.233718
• Pratyusha Bala, Anurag Kumar Singh, Padmavathi Kavadipula, Viswakalyan Kotapalli, Radhakrishnan Sabarinathan, Murali Dharan Bashyam. Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer. Under review with Oncogene, 2020
• Murali Dharan Bashyam, Srinivas Animireddy*, Pratyusha Bala*, Ashmala Naz* and Sara Anisa George*. The yin and yang of cancer genes. Gene, 2019; in press. (*, equal contribution)
• Murali Dharan Bashyam, Srinivas Animireddy* and Pratyusha Bala*. Taming the Master: SWI/SNF chromatin remodeler as a therapeutic target in cancer. Current Science, 2019; in press. (*, equal contribution)